ESLA
Estrella Immunopharma Inc.
0.481$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 100.0% | 0.5% | 100.0% | 52.2% | 52.8% | |
| – | 83.1% | 0.4% | 93.5% | 29.2% | 43.6% | |
| – | 83.1% | 0.4% | – | 29.2% | 43.6% | |
| – | – | 2.7% | – | 9.2% | – | |
| – | 121.1% | 29.2% | 4.1% | 95.4% | 426.3% | |
| – | 19.2% | 10.7% | 4.1% | 95.4% | 426.3% | |
| – | – | 5.0% | – | – | – | |
| – | 19.2% | 0.5% | 0.0% | 2.5% | 17.5% | |
| – | -21.1% | 70.8% | 95.9% | 4.6% | -326.3% | |
| – | -21.8% | -22.6% | -437.8% | -761.8% | -1,164.3% | |
| – | 715.2% | 352.5% | 814.7% | 1,167.9% | 1,159.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.